
Bruker Corp
BRKRNasdaqCIK 1109354TechnologyFiscal year ends Dec 31
Reports and events: 309 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-04-2207:16 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-049697 |
| 2024-04-1916:34 ET | DEF 14A | Proxy statementPeriod 2024-05-30 | 0000950170-24-046045 |
| 2024-04-0209:28 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950170-24-039776 |
| 2024-02-2915:58 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-023038 |
| 2024-02-1307:39 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-014189 |
| 2024-02-1207:02 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950170-24-013561 |
| 2024-02-0216:38 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950170-24-010557 |
| 2024-01-1920:29 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950170-24-005565 |
| 2024-01-0812:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0000950170-24-002823 |
| 2023-12-2609:00 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure | 0000950170-23-072832 |
| 2023-11-0916:54 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-062192 |
| 2023-11-0207:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-057737 |
| 2023-08-0915:27 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-040491 |
| 2023-08-0307:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-037567 |
| 2023-06-0717:16 ET | 8-K | 5.07 Shareholder vote results | 0000950170-23-026851 |
| 2023-05-1516:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-022180 |
| 2023-05-1015:10 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-020404 |
| 2023-05-0407:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-017460 |
| 2023-04-2816:19 ET | DEF 14A | Proxy statement | 0000950170-23-015837 |
| 2023-03-0118:20 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-005251 |
| 2023-02-2107:00 ET | 8-K | 8.01 Other events | 0000950170-23-003292 |
| 2023-02-0907:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-002241 |
| 2023-01-0911:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0000950170-23-000482 |
| 2022-11-0415:11 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-022163 |
| 2022-11-0307:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-021537 |
| 2022-08-0515:12 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-015090 |
| 2022-08-0316:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-014277 |
| 2022-06-0116:20 ET | 8-K | 5.07 Shareholder vote results | 0001193125-22-165198 |
| 2022-05-0614:05 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000950170-22-008094 |
| 2022-05-0407:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-007184 |
| 2022-04-2216:01 ET | DEF 14A | Proxy statementPeriod 2022-06-01 | 0001193125-22-115070 |
| 2022-03-1609:55 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-22-076869 |
| 2022-02-2810:46 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001193125-22-056531 |
| 2022-02-1107:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-035665 |
| 2022-01-1007:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001193125-22-005065 |
| 2021-12-0807:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-21-350814 |
| 2021-11-0516:01 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001193125-21-321572 |
| 2021-11-0116:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-315384 |
| 2021-08-2016:16 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-21-252755 |
| 2021-08-0509:14 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001193125-21-237150 |
| 2021-08-0216:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-233233 |
| 2021-06-1708:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-192728 |
| 2021-06-0716:05 ET | 8-K | 5.07 Shareholder vote results | 0001193125-21-184282 |
| 2021-06-0207:00 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-21-179208 |
| 2021-05-1308:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-159866 |
| 2021-05-1018:31 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001193125-21-155172 |
| 2021-05-0507:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-150744 |
| 2021-04-2016:31 ET | DEF 14A | Proxy statementPeriod 2021-06-04 | 0001193125-21-122904 |
| 2021-04-1316:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-114712 |
| 2021-03-0115:37 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001104659-21-029938 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 16:58 ET. Listed shows no prices and gives no investment advice.